186 related articles for article (PubMed ID: 38762130)
1. Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer's disease research.
Singhaarachchi PH; Antal P; Calon F; Culmsee C; Delpech JC; Feldotto M; Geertsema J; Hoeksema EE; Korosi A; Layé S; McQualter J; de Rooij SR; Rummel C; Slayo M; Sominsky L; Spencer SJ
Neurosci Biobehav Rev; 2024 Jul; 162():105724. PubMed ID: 38762130
[TBL] [Abstract][Full Text] [Related]
2. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.
Hopperton KE; Trépanier MO; James NCE; Chouinard-Watkins R; Bazinet RP
Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025
[TBL] [Abstract][Full Text] [Related]
3. The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease.
de Wit NM; Mol K; Rodríguez-Lorenzo S; de Vries HE; Kooij G
Front Immunol; 2020; 11():620348. PubMed ID: 33633739
[TBL] [Abstract][Full Text] [Related]
4. Resolution of inflammation, n-3 fatty acid supplementation and Alzheimer disease: A narrative review.
Fraga VG; Carvalho MDG; Caramelli P; de Sousa LP; Gomes KB
J Neuroimmunol; 2017 Sep; 310():111-119. PubMed ID: 28778434
[TBL] [Abstract][Full Text] [Related]
5. Eicosanoid signaling in neuroinflammation associated with Alzheimer's disease.
Lohitaksha K; Kumari D; Shukla M; Byagari L; Ashireddygari VR; Tammineni P; Reddanna P; Gorla M
Eur J Pharmacol; 2024 Aug; 976():176694. PubMed ID: 38821162
[TBL] [Abstract][Full Text] [Related]
6. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain.
Emre C; Hjorth E; Bharani K; Carroll S; Granholm AC; Schultzberg M
Brain Pathol; 2020 May; 30(3):614-640. PubMed ID: 31912564
[TBL] [Abstract][Full Text] [Related]
7. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
8. Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition.
Ooi KM; Vacy K; Boon WC
Neurochem Int; 2021 Oct; 149():105143. PubMed ID: 34311029
[TBL] [Abstract][Full Text] [Related]
9. Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment.
Fiala M; Terrando N; Dalli J
J Alzheimers Dis; 2015; 48(2):293-301. PubMed ID: 26401996
[TBL] [Abstract][Full Text] [Related]
10. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
11. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
Heininger K
Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
[TBL] [Abstract][Full Text] [Related]
12. Roles of Cytokines in Alzheimer's Disease.
Chen Z; Balachandran YL; Chong WP; Chan KWY
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891990
[TBL] [Abstract][Full Text] [Related]
13. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation.
Joffre C; Rey C; Layé S
Front Pharmacol; 2019; 10():1022. PubMed ID: 31607902
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer's Disease Progression.
Andronie-Cioara FL; Ardelean AI; Nistor-Cseppento CD; Jurcau A; Jurcau MC; Pascalau N; Marcu F
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768235
[TBL] [Abstract][Full Text] [Related]
15. n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging.
Joffre C; Dinel AL; Chataigner M; Pallet V; Layé S
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121189
[No Abstract] [Full Text] [Related]
16. The Role of Chemokines in Alzheimer's Disease.
Jorda A; Campos-Campos J; Iradi A; Aldasoro M; Aldasoro C; Vila JM; Valles SL
Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1383-1390. PubMed ID: 32003705
[TBL] [Abstract][Full Text] [Related]
17. The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models.
Ma QL; Zhu C; Morselli M; Su T; Pelligrini M; Lu Z; Jones M; Denver P; Castro D; Gu X; Relampagos F; Caoili K; Teter B; Frautschy SA; Cole GM
Front Immunol; 2020; 11():558036. PubMed ID: 33178186
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acids, specialized pro-resolving mediators, and targeting inflammation resolution in the age of precision nutrition.
Al-Shaer AE; Buddenbaum N; Shaikh SR
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jul; 1866(7):158936. PubMed ID: 33794384
[TBL] [Abstract][Full Text] [Related]
19. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain.
Rey C; Delpech JC; Madore C; Nadjar A; Greenhalgh AD; Amadieu C; Aubert A; Pallet V; Vaysse C; Layé S; Joffre C
Brain Behav Immun; 2019 Feb; 76():17-27. PubMed ID: 30086401
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
